Assoc Prof Dr. Lishu Guo at Columbia University, China
👨🎓 Profiles
📚 Academic Background
Lishu Guo is an accomplished Associate Research Scientist at Columbia University, New York, specializing in mitochondrial bioenergetics and metabolic reprogramming. With a global academic and research background, Dr. Guo has contributed significantly to understanding mitochondrial dynamics and their implications in cancer and metabolic disorders.
🎓 Education
Dr. Guo earned a Ph.D. in Biomedical Science from the University of Padova, Italy, focusing on mitochondrial permeability transition and F-ATP synthase (2015-2018). She also holds a Master’s in Pharmacology from Lanzhou University, China (2012-2014), and a Bachelor’s in Medicine from Henan University, China (2008-2012).
💼 Professional Experience
Dr. Guo is currently serving as an Associate Research Scientist at Columbia University’s Department of Anesthesiology (since August 2024). Previously, she worked as a Young Associate Researcher at the Greater Bay Area Institute of Precision Medicine, Fudan University, China (2022-2024) and as an Assistant Researcher at Tongji University’s School of Medicine, China (2019-2022). She also completed a Fellowship at the University of Padova (2018-2019) and started her career as an Assistant Researcher at Shanghai Haohai Biological Technology Co., Ltd. (2014-2015).
🔬 Research Interests
Dr. Guo’s research interests include mitochondrial channels and permeability transition, oxidative phosphorylation, F-ATP synthase dynamics, oxidative stress, calcium homeostasis, and metabolic reprogramming. She explores these areas to understand their roles in cellular function and disease mechanisms.
🏆 Awards and Funding
Dr. Guo has received funding from the Shanghai Sailing Program (2020-2023) and the Shanghai Tenth People’s Hospital (2021-2023).
🤝 Memberships
Dr. Guo is a member of the Shanghai Overseas Returned Scholars Association and the Guangzhou Overseas Returned Scholars Association.
📝 Reviewer
Dr. Guo serves as a reviewer for several journals, including ACS Chemical Neuroscience, Biochemical Pharmacology, and Mitochondrial Communications.
💡Patents
Dr. Guo holds patents for MTCH2 in cancer treatment drugs related to iron death (2023) and a composition for enhancing immune function (2023).
📖 Publications